India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Los Alamitos Race Course is facing its most serious crisis in years after 18 horses died in 2025, prompting regulators to warn the track that its racing license is at risk without immediate safety reforms. Following three catastrophic injuries in a single day, the California Horse Racing Board has ordered urgent changes—including more veterinarians, stricter medication rules, and enhanced on‑track medical support—as pressure mounts for stronger oversight in a sport already under national scrutiny.
Canadian investors have poured more than US$5.8 billion into U.S. commercial real estate this year, making the U.S. their top destination even amid a lingering tariff dispute. Tight inventory in Canada and greater deal availability south of the border are driving the trend, with data centers and industrial properties emerging as the hottest targets for 2025.
Florida’s insurance commissioner says even industry pros struggle to read today’s 150‑page homeowners policies—leaving residents shocked when hurricane claims are denied. With rising premiums, high replacement costs, and widespread confusion over exclusions like flood and water damage, the state is pushing for simpler, clearer policy language so homeowners know what they’re actually covered for before the next storm hits.
Following the 2025 elections, major metros like New York, Chicago, Miami, Los Angeles, and Boston are implementing policy shifts that could reshape property values, rental income, development timelines, and investment strategy heading into 2026. From New York’s push toward aggressive rent reform to Chicago’s sustainability mandates and Miami’s uncertain mayoral runoff, these changes signal a new era where local politics increasingly dictate market performance. This breakdown highlights the biggest post‑election real estate pivots and what they mean for investors, agents, and finance professionals preparing for a rapidly evolving landscape.
Florida’s Insurance Commissioner is sounding the alarm after thousands of homeowners discovered—only after hurricanes Helene and Milton—that the coverage they thought they had didn’t exist. With nearly 150,000 unpaid claims tied to misunderstood flood exclusions, water‑damage caps, and buried policy clauses, state leaders are pushing to simplify the dense, confusing documents most Floridians never read. As insurance costs remain one of the state’s top concerns, this growing complexity is creating a massive opportunity for real estate, mortgage, and insurance professionals to guide consumers before disaster strikes.
Florida’s insurance market is reliving an old crisis under a new name. Despite reforms meant to stabilize the system, homeowners are being forced out of Citizens and into pricier policies from small insurers with shaky financial histories. Companies tied to past insolvencies are returning with fresh branding, while highly rated carriers continue to deny a majority of claims. With political influence muddying regulation and climate risks rising, experts warn that only a full structural overhaul—not cosmetic reforms—can restore confidence for homeowners, agents, and the entire real estate market.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
